Your browser doesn't support javascript.
loading
Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.
Arvold, Nils D; Tanguturi, Shyam K; Aizer, Ayal A; Wen, Patrick Y; Reardon, David A; Lee, Eudocia Q; Nayak, Lakshmi; Christianson, Laura W; Horvath, Margaret C; Dunn, Ian F; Golby, Alexandra J; Johnson, Mark D; Claus, Elizabeth B; Chiocca, E Antonio; Ligon, Keith L; Alexander, Brian M.
Afiliación
  • Arvold ND; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Tanguturi SK; Harvard Radiation Oncology Program, Boston, Massachusetts.
  • Aizer AA; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Wen PY; Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Reardon DA; Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Lee EQ; Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Nayak L; Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Christianson LW; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Horvath MC; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Dunn IF; Department of Neurosurgery, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Golby AJ; Department of Neurosurgery, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Johnson MD; Department of Neurosurgery, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Claus EB; Department of Neurosurgery, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts; School of Public Health, Yale University, New Haven, Connecticut.
  • Chiocca EA; Department of Neurosurgery, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Ligon KL; Department of Pathology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Alexander BM; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts. Electronic address: bmalexander@lroc.harvard.edu.
Int J Radiat Oncol Biol Phys ; 92(2): 384-9, 2015 Jun 01.
Article en En | MEDLINE | ID: mdl-25841623

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_brain_nervous_system_cancer Asunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / Dacarbazina Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_brain_nervous_system_cancer Asunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / Dacarbazina Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2015 Tipo del documento: Article
...